The HHLA2 gene, however, was highly expressed in BMDMs of MD-susceptible line 72, which presumably implicates it in a novel immunosuppressive mechanism within the microenvironment of metastatic disease [65]. The gene discussed is HHLA2; the disease is metastatic neoplasm.